Baxter International | Despesas Operacionais





Despesas Operacionais Alterar Data
Abbott USD 9.21B 17M 2025-12
AngioDynamics USD 81.98M 1.96M 2025-02
Artivion USD 56.62M 195K 2024-09
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 158.83M 69.83M 2025-09
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cooper Companies USD 924.8M 40.2M 2025-09
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Fresenius EUR 4.91B 110M 2025-09
Globus Medical USD 886.57M 730.06M 2025-09
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 1.04B 620.66M 2025-09
Intuitive Surgical USD 2B 263.6M 2025-12
J&J USD 18.97B 2.38B 2025-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Masimo USD 147M 159.4M 2025-09
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 341.54M 6.11M 2025-09
Quest Diagnostics USD 2.42B 4.84B 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.82B 3.22B 2025-09
Terumo JPY 252.74B 22.88B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12


Baxter International Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.